Medical Mycology Journal

Scope & Guideline

Fostering Collaboration in the Fight Against Fungal Diseases

Introduction

Explore the comprehensive scope of Medical Mycology Journal through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Medical Mycology Journal in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN2185-6486
PublisherJAPANESE SOC MEDICAL MYCOLOGY
Support Open AccessNo
CountryJapan
TypeJournal
Convergefrom 2011 to 2024
AbbreviationMED MYCOL J / Med. Mycol. J.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4-12 OHKUBO, SHINJYUKU-KU, TOKYO 169-0072, JAPAN

Aims and Scopes

The Medical Mycology Journal focuses on advancing the understanding of fungal pathogens and their interactions with humans, emphasizing clinical relevance and therapeutic strategies. Its core areas include basic and applied research in medical mycology, providing insights into fungal diseases, diagnostics, and treatment methodologies.
  1. Fungal Pathogenesis and Virulence Mechanisms:
    Research exploring the mechanisms by which fungi cause disease, including studies on virulence factors, host-pathogen interactions, and environmental influences on fungal pathogenicity.
  2. Antifungal Therapy and Drug Resistance:
    Investigation into antifungal treatments, including optimal therapeutic strategies, drug resistance mechanisms, and the development of new antifungal agents.
  3. Diagnostic Innovations in Mycology:
    Focus on improving diagnostic methods for fungal infections, including molecular techniques, serological assays, and the identification of novel biomarkers for various fungal diseases.
  4. Epidemiology of Fungal Infections:
    Studies examining the distribution, prevalence, and trends of fungal infections in different populations, alongside the impact of environmental factors on fungal epidemiology.
  5. Clinical Case Studies and Guidelines:
    Publication of clinical case reports and evidence-based guidelines to inform practitioners about the diagnosis and management of fungal diseases.
  6. Mycobiome Research:
    Exploration of the human mycobiome and its association with health and disease, including the role of fungal communities in human microbiomes.
The Medical Mycology Journal has seen an increase in the focus on specific themes that reflect the current challenges and advancements in the field of medical mycology. These emerging areas signify a dynamic shift towards innovative research and clinical applications.
  1. Antifungal Stewardship and Resistance Management:
    There is a growing emphasis on antifungal stewardship programs aimed at optimizing antifungal use and managing resistance, reflecting global health priorities in combating fungal infections.
  2. Role of Artificial Intelligence in Diagnostics:
    Emerging research on the application of artificial intelligence in the diagnosis of fungal infections is gaining traction, indicating a trend towards integrating technology with clinical mycology.
  3. In Vivo Models for Fungal Research:
    Increased utilization of in vivo models, such as silkworm and murine models, for studying fungal infections and treatment efficacy suggests a trend towards more relevant experimental frameworks.
  4. Molecular Epidemiology and Genomic Studies:
    A rise in molecular epidemiology studies, including genomic analyses to understand the spread and resistance mechanisms of fungal pathogens, indicates a focus on precision medicine.
  5. Exploration of Mycobiome and Associated Diseases:
    Research into the human mycobiome and its implications for health and disease is emerging as a significant area of interest, highlighting the complex interactions between fungi and human health.

Declining or Waning

As the field of medical mycology evolves, certain themes appear to be diminishing in frequency within the journal's recent publications. These declining scopes may reflect shifts in research priorities or emerging methodologies.
  1. Traditional Culture Methods for Fungal Identification:
    There has been a noticeable decrease in studies focusing solely on classical culture methods for identifying fungal pathogens, as molecular techniques gain prominence in diagnostics.
  2. Non-Specific Antifungal Agents:
    Research centered on broad-spectrum antifungal agents is waning, with a shift towards more targeted therapies and personalized medicine approaches in antifungal treatment.
  3. Basic Taxonomic Studies without Clinical Relevance:
    Taxonomic research that does not have clear clinical implications or applications is becoming less common, as the journal increasingly prioritizes studies that bridge basic research and clinical practice.
  4. Environmental Mycology Studies with Limited Clinical Application:
    Research focused purely on environmental mycology, such as studies on fungal biodiversity without direct implications for human health, is appearing less frequently.

Similar Journals

MYCOLOGIA

Advancing fungal research for a sustainable future.
Publisher: TAYLOR & FRANCIS INCISSN: 0027-5514Frequency: 6 issues/year

MYCOLOGIA, published by Taylor & Francis Inc, is a prestigious journal that has been at the forefront of fungal research since its inception, with converging years of publication from 1945 to 2024. This interdisciplinary journal, identified by ISSN 0027-5514 and E-ISSN 1557-2536, stands out in various scientific categories, achieving Q1 rankings in Ecology, Evolution, Behavior and Systematics, as well as Plant Science, alongside strong performances in Cell Biology and Molecular Biology categories. With an impact factor that reflects its significance in the field, MYCOLOGIA appeals to a diverse audience, including researchers, professionals, and students dedicated to advancing the understanding of fungal biology and its ecological implications. Notably, while it does not currently operate under an Open Access model, the journal remains a vital resource for those pursuing groundbreaking discoveries in mycology and related disciplines.

mSphere

Fostering innovation in microbial and molecular sciences.
Publisher: AMER SOC MICROBIOLOGYISSN: Frequency: 6 issues/year

mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

MYCOPATHOLOGIA

Driving innovation in mycology and plant science.
Publisher: SPRINGERISSN: 0301-486XFrequency: 6 issues/year

MYCOPATHOLOGIA, published by Springer in the Netherlands, stands as a pivotal journal in the fields of mycology, plant science, and veterinary microbiology. With its extensive history dating back to 1938, this journal has consistently contributed to the understanding of fungal pathogens and their impact on both agriculture and animal health. It currently holds impressive rankings in Scopus, including Q1 status in Agronomy and Crop Science, and Q2 rankings in Applied Microbiology and Biotechnology, demonstrating its influence and rigor in the scientific community. Researchers and professionals benefit from its curated, high-quality studies which address critical areas such as plant-pathogen interactions and veterinary mycology. While not open access, MYCOPATHOLOGIA emphasizes comprehensive research output and serves as a vital resource for advancing knowledge and fostering innovation in its disciplines. The journal remains committed to disseminating valuable insights that drive forward both academic inquiry and practical applications in related fields, ensuring its relevance and importance in contemporary research.

MYCOSES

Advancing mycological insights for clinical excellence.
Publisher: WILEYISSN: 0933-7407Frequency: 12 issues/year

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Medical Mycology Case Reports

Bridging clinical cases and academic excellence in mycology.
Publisher: ELSEVIERISSN: 2211-7539Frequency:

Medical Mycology Case Reports, published by Elsevier, is a pivotal journal dedicated to advancing the field of mycology through the presentation of case reports that highlight clinical findings, diagnostic challenges, and treatment outcomes associated with fungal infections. With its ISSN 2211-7539 and E-ISSN 2211-7539, this open-access journal has been serving the global community since 2012, allowing unrestricted access to its valuable insights. Situated in the Netherlands, specifically at RADARWEG 29, AMSTERDAM, this journal has gained recognition in areas such as Infectious Diseases (ranked Q3) and Microbiology (ranked Q4) as of 2023. Its commitment to disseminating high-quality research is reflected in its Scopus rankings, which place it at the 51st percentile in Medicine and the 32nd percentile in Immunology and Microbiology. By bridging the gap between clinical cases and academic research, Medical Mycology Case Reports plays a crucial role in enriching the knowledge base of practitioners and researchers alike, ultimately contributing to improved patient management and public health.

Journal of Pediatric Infection

Transforming pediatric care with cutting-edge insights.
Publisher: AVES YAYINCILIK, IBRAHIM KARAISSN: 1307-1068Frequency: 4 issues/year

Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.

RESEARCH IN MICROBIOLOGY

Illuminating the complexities of life at the microscopic level.
Publisher: ELSEVIERISSN: 0923-2508Frequency: 8 issues/year

Research in Microbiology, published by Elsevier, is a prominent academic journal devoted to advancing the field of microbiology, encompassing a diverse array of topics including immunology, molecular biology, and biochemistry. Established in 1987, the journal has expanded its focus over the years, with a commendable impact factor reflecting its relevance and influence in the scientific community. Although it does not currently offer open access options, Research in Microbiology remains a crucial resource for researchers and professionals seeking to stay abreast of the latest findings and methodologies. The journal holds a respectable Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in both Microbiology and Molecular Biology for 2023, highlighting its position within the scholarly landscape. With its base in France and accessible to a global audience, Research in Microbiology continues to foster scholarly exchange, making it an essential platform for the dissemination of impactful microbiological research.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY

Fostering scholarly dialogue in medical microbiology and immunology.
Publisher: SPRINGERISSN: 0300-8584Frequency: 6 issues/year

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

MycoKeys

Pioneering discoveries in fungal biology and ecosystems.
Publisher: PENSOFT PUBLISHERSISSN: 1314-4057Frequency: 2 issues/year

MycoKeys, published by PENSOFT PUBLISHERS, is a leading open-access journal dedicated to advancing the understanding of fungal biology and its diverse implications within agricultural, ecological, and biological sciences. With its ISSN 1314-4057 and E-ISSN 1314-4049, this journal has achieved remarkable academic prestige, reflected in its 2023 Scopus rankings placing it in the first quartile (Q1) across several categories, including Agricultural and Biological Sciences (miscellaneous), Ecology, Evolution, Behavior and Systematics, and Plant Science. MycoKeys provides a platform for researchers, professionals, and students interested in the latest findings and methodologies regarding fungi, their environments, and their interactions within various ecosystems. Since its transition to open access in 2011, the journal has championed the dissemination of high-quality research to a global audience, fostering collaboration and innovation in mycology. With a publishing history that converges from 2015 to 2024, MycoKeys remains a vital resource for those committed to exploring the multifaceted roles fungi play in our world.

SYDOWIA

Navigating the Frontiers of Ecological and Botanical Research
Publisher: VERLAG FERDINAND BERGER SOHNE GESELLSCHAFT MBHISSN: 0082-0598Frequency: 1 issue/year

SYDOWIA is a prestigious academic journal based in Austria, published by Verlag Ferdinand Berger Sohne Gesellschaft mbH, that has been a cornerstone of scientific publishing since its establishment in 1996. With an ISSN of 0082-0598, SYDOWIA focuses on critical research in the fields of Ecology, Evolution, Behavior and Systematics as well as Plant Science, earning a notable classification in Category Quartiles with Q3 in Ecology-related disciplines and Q2 in Plant Science for 2023. The journal’s strategic insights into agricultural and biological sciences have secured a place within the Scopus rankings, where it holds the position of #191 out of 516 in Plant Science and #278 out of 721 in Ecology categories—reflecting its growing influence with a percentile standing of 63rd and 61st, respectively. Although SYDOWIA is not an Open Access journal, it continues to thrive in delivering scholarly articles that promote advancement and innovation in ecological and botanical research. Researchers, professionals, and students alike can rely on SYDOWIA as a vital resource for disseminating knowledge and fostering exploration in these essential scientific domains.